Skip to main content
. Author manuscript; available in PMC: 2018 Jun 27.
Published in final edited form as: Lab Chip. 2017 Jun 27;17(13):2243–2255. doi: 10.1039/c7lc00327g

Table 1.

Short-term viability and long-term proliferation of 7 cancer cell lines after exposures to the custom-made biocompatible ferrofluid. Short-term viability was determined by a Live/Dead assay after 2-hour exposure to the ferrofluid with a 0.26% volume fraction ferrofluid. Long-term proliferation was determined by culturing cells after the same exposure to the ferrofluid.

Cell line A549
(Lung
cancer)		 H1299
(Lung
cancer)		 HeLa
(Cervical
cancer)		 MDA-
MB-231
(Breast
cancer)		 HCC1806
(Breast
cancer)		 MCF-7
(Breast
cancer)		 PC3
(Prostate
cancer)
Viability after 2-hour exposure to ferrofluids 94% 95% 92% 95% 94% 95% 96%
Proliferation to confluence after 2-hour exposure to ferrofluids Yes Yes Yes Yes Yes Yes Yes